Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Non-Current Deffered Revenue (2016 - 2019)

Historic Non-Current Deffered Revenue for Forte Biosciences (FBRX) over the last 4 years, with Q1 2019 value amounting to -$2.3 million.

  • Forte Biosciences' Non-Current Deffered Revenue fell 153687.5% to -$2.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$2.3 million, marking a year-over-year decrease of 153687.5%. This contributed to the annual value of $2.2 million for FY2018, which is 601388.89% up from last year.
  • As of Q1 2019, Forte Biosciences' Non-Current Deffered Revenue stood at -$2.3 million, which was down 153687.5% from $2.2 million recorded in Q4 2018.
  • Forte Biosciences' 5-year Non-Current Deffered Revenue high stood at $2.2 million for Q4 2018, and its period low was -$2.3 million during Q1 2019.
  • In the last 4 years, Forte Biosciences' Non-Current Deffered Revenue had a median value of $64500.0 in 2016 and averaged $389600.0.
  • Per our database at Business Quant, Forte Biosciences' Non-Current Deffered Revenue surged by 601388.89% in 2018 and then plummeted by 153687.5% in 2019.
  • Forte Biosciences' Non-Current Deffered Revenue (Quarter) stood at $68000.0 in 2016, then tumbled by 47.06% to $36000.0 in 2017, then soared by 6013.89% to $2.2 million in 2018, then plummeted by 204.45% to -$2.3 million in 2019.
  • Its last three reported values are -$2.3 million in Q1 2019, $2.2 million for Q4 2018, and $2.0 million during Q3 2018.